Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing canagliflozin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Canagliflozin 500 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Canagliflozin 300 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing canagliflozin and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Canagliflozin- and metformin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Canagliflozin hemihydrate (substance) |
Is a |
False |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely canagliflozin 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely canagliflozin 100 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing canagliflozin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only canagliflozin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only canagliflozin and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Canagliflozin and metformin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only canagliflozin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Canagliflozin hemihydrate (substance) |
Is modification of (attribute) |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely canagliflozin (as canagliflozin hemihydrate) 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely canagliflozin 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely canagliflozin 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to canagliflozin |
Causative agent (attribute) |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Canagliflozin anhydrous |
Is modification of (attribute) |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Canagliflozin 150 mg and metformin hydrochloride 850 mg oral tablet |
Has precise active ingredient |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Canagliflozin 150 mg and metformin hydrochloride 850 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely canagliflozin 150 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely canagliflozin 150 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Canagliflozin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |